Bayer AG (OTCPK:BAYZF) Q4 2023 Earnings Conference Call March 5, 2024 3:30 AM ET Company Participants Michael Preuss - Head, Communications, Government Relations and Corporate Brand Julio Triana - Head, Commercial Operations Region International William Anderson - Chairman & CEO Heike Prinz - Chief Talent Officer & Labor Director Heiko Schipper - President, Consumer Health Division Wolfgang Nickl - CFO Stefan Oelrich - Head, Pharmaceuticals Division Rodrigo Santos - President, Crop Science Division Conferen ...

The Stoxx 600 index will be in the spotlight this week as the European Central Bank (ECB) delivers its second interest rate decision of the year. The index, which tracks the biggest European companies, surged to a record high of €497, which was about 30% above its lowest point in December 2022.ECB interest rate decision aheadCopy link to sectionThe biggest forex and stock market news this week will be the latest decision by the ECB, which is set for Thursday. Economists polled by Reuters expect that the ban ...

Bayer announced plans to cut its dividend a staggering 95% over the next three years as it looks to recover from debt associated with its acquisition of Monsanto Co., which thrust the German corporation to the center of multiple lawsuits involving Roundup weed killer.The dividend cut was expected, according to Bloomberg, which said that the reduction underscores the company’s struggle to recover from its $63 billion takeover of Roundup-maker Monsanto in 2018.Bayer said it will offer investors only the legal ...

Bayer AG (BAYRY) announced plans to cut its dividend rate for 2023.Following a review of the company’s capital allocation priorities to reduce debt, BAYRY plans to amend its dividend policy to pay out only the legally required minimum for three years.Consequently, the decision will reduce the dividend to €0.11 per share for 2023 compared with €2.40 in 2022.This proposal comes as the company faces a high level of debt, coupled with high-interest rates and a challenging free cash flow situation.The ongoing gl ...

Bayer was ordered to pay $2.25 billion after a Pennsylvania jury unanimously ruled that its Roundup weed killer gave a man cancer.John McKivinson, 49, who was diagnosed with non-Hodgkin’s lymphoma, sued Roundup maker Monsanto and its corporate parent, Bayer, saying he developed the cancer after using the herbicide on his property for two decades.The massive payout includes $2 billion in punitive damages, McKivinson’s attorneys at Kline & Specter told The Post on Tuesday.Jury members also found that Monsant ...

Bayer AG (ETR:BAYN, OTC:BAYZF) will find it tough to hit last year's targets and faces multiple adverse factors in 2024, said Stifel as it downgraded the German pharma giant and cut its share price target.  The US bank removed its 'buy' rating with a switch to a 'hold' stance with a reduced price target of €42 from €68. Analysts think Bayer "will find it tough" to reach the lower end of the 2023 earnings guidance of €11.3 billion excluding current effects.  According to new Bayer chief executive Bill Anders ...

Bayer AG (BAYRY) announced that the late-stage studies on the investigational compound elinzanetant were successful.Elinzanetant is the first dual neurokinin-1,3 receptor antagonist in late-stage clinical development for the non-hormonal treatment of moderate to severe vasomotor symptoms (“VMS”), also known as hot flashes associated with menopause, administered orally once daily.The phase III studies, OASIS 1 and 2 are double-blind, randomized, placebo-controlled multicenter studies investigating the effica ...

About this content About Andrew Kessel Andrew is a financial journalist with experience covering public companies in a wide breadth of industries, including tech, medicine, cryptocurrency, mining and retail. In addition to Proactive, he has been published in a Financial Times-owned newsletter covering broker-dealer firms and in the Columbia Misourian newspaper as the lead reporter focused on higher education. He got his start with an internship at Rolling Stone magazine.  Read more About the publisher Pr ...

| --- | --- | --- | --- | |-----------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | Q3 2023 | | | | | Investor Webinar //////////////// | | | | | November 8th, 2023 | | | | Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between ...

Bayer Aktiengesellschaft (OTCPK:BAYZF) Q3 2023 Earnings Conference Call November 8, 2023 8:00 AM ET Company Participants Jost Reinhard - Senior Vice President & Head-Investor Relations Bill Anderson - Chief Executive Officer Wolfgang Nickl - Chief Financial Officer Rodrigo Santos - President, Crop Science Division Stefan Oelrich - President, Pharmaceuticals Division Heiko Schipper - President, Consumer Health Division Conference Call Participants Peter Verdult - Citi Sachin Jain - Bank of America Vincent An ...